Shanzhi Gu

机构：Central South University, Hunan Cancer Hospital

发表论文 20 篇 · 总被引 74 次 · h-index 5

代表论文

• C hinese expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2014 · Thoracic Cancer · 被引 29)
• 18 F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model (2017 · Radiology · 被引 12)
• Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial (2025 · European Journal of Cancer · 被引 11)
• First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors (2024 · npj Precision Oncology · 被引 9)
• Comparison of Efficacy between Lenvatinib and Bevacizumab in Combination of Immune Checkpoint Inhibitor and Interventional Triple Therapy in Chinese Advanced Hepatocellular Carcinoma: The CLEAP 2302 Study (2025 · Liver Cancer · 被引 6)
• Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study (2025 · Clinical Cancer Research · 被引 4)